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The coupling of myocardial oxygen consumption (MVOz)
with its determinants in left ventricular hypertrophy in
human beings is poorly understood. Therefore, ther-
modilution-derlved coronary blood flow, MV02and left
ventricular wall stress, obtained from simultaneous left
ventricular M-mode echogram and pressure, were com-
pared in 32 patients with various degrees of left ven-
tricular hypertrophy. Patients were studied at rest and
after mechanical load alteration with nitroglycerin or
phenylephrine. Decreases in MV02( - 5.7 ± 0.8 ml/min;
p < 0.001) and the time integral of meridional ejection
stress or shortening load (- 1,297 ± 152 x 103
dynes-s/cm'; p < 0.001) were observed after nitrogly-
cerin administration while increases in MV02(+5.5 ±
0.7 ml/min; p < 0.001) and shortening load (+ 1,412 ±
137 x 103 dynes-s/cm'; p < 0.001) were noted after
phenylephrine. An index relating the change in MVOz
The dependence of left ventricular myocardial oxygen con-
sumption (MV02) on heart rate, contractility and systolic
wall force is well recognized. However, the effects of chronic
mechanical load increases and resultant left ventricular hy-
pertrophy on this relation are less well understood (1-5).
In addition, little information is available in human beings
on the effects of left ventricular dysfunction on the relation
between MV02 and wall force. Because changes in myo-
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to the corresponding change in shortening load (SL),
%~MV02/%~SL, was significantly different in patients
without (Group 1) and with (Group 2) clinical left ven-
tricular failure. Left ventricular mass was similar in both
groups. The mean %~MVOz/%~SL with phenylephrine
in Group 1 (79.6 ± 9.6) was greater than the index for
Group 2 (35.5 ± 6.1; p < 0.005). With nltroglycerin,
Group 2 patients exhibited a greater reduction in
%~MVOz/%~SL (110.5 ± 17.8) than Group 1 (54.0 ±
9.4; p < 0.01).
In conclusion, in patients with left ventricular hy-
pertrophy and dysfunction there appears to be a state
of diminished coronary flow response to load augmen-
tation. However, load reduction in patients with clinical
left ventricular failure results in a more balanced rela-
tion between oxygen uptake and ejection stress,
cardial oxygen demand are met by corresponding changes
in coronary blood flow. the ability of the coronary circu-
lation to adapt to primary alterations in myocardial oxygen
demand may be of critical importance to the mechanically
overloaded left ventricle. Several studies recently have dem-
onstrated diminished coronary blood flow reserve in patients
with left ventricular hypertrophy, as assessed by observing
the hyperemic response to intraoperative coronary occlusion
(6,7) or pharmacologic stimuli that provoke coronary hy-
peremia (8,9). However. the implications of these data for
the regulation of coronary blood flow in response to changes
in myocardial oxygen demand as a result of load alteration
are unclear.
Recently. we have shown that the "shortening load." or
the time integral of left ventricular wall stress during ejec-
tion, is sensitive to load alteration and closely parallels
changes in MV02 in the normal and hypertrophied human
left ventricle (10). This study examines the changes in coro-
nary blood flow and MV02 with load alteration in a group
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of patients with various degrees of left ventricular dysfunc-
tion and hypertrophy. Differences in the matching of changes
in MV02 and changes in shortening load are demonstrated
between patients with normal and decompensated pump
function.
Methods
Patients. Thirty-two patients undergoing clinically in-
dicated diagnostic cardiac catheterization form the basis of
this report. A technically optimal left ventricular M-mode
echogram, angiographically normal coronary arteries and
symmetric left ventricular contraction patterns on ventric-
ulography were criteria for inclusion in this study. All pa-
tients were in sinus rhythm. None had received vasodilators,
including nitrates, within 12 hours of study but digitalis and
diuretic therapy were continued. Of the 32 patients (Table
I) there were 6 normal subjects, II patients with volume
overload left ventricular hypertrophy (mitral regurgitation in
7, aortic regurgitation in 3, ventricular septal defect in I),
9 patients with pressure overload left ventricular hypertro-
phy (aortic stenosis in 6, hypertensive heart disease in 3)
and 6 patients with congestive cardiomyopathy. There were
20 men and 12 women whose ages ranged from 21 to 73
years (mean 53). Left ventricular ejection fraction ranged
from 0.10 to 0.78 with 14 of the 32 patients having an
ejection fraction of 0.50 or less.
Study protocol. Baseline measurements. During car-
diac catheterization and before angiography, aortic and left
ventricular pressures were measured with a single or double
transducer micromanometer-tip catheter (Millar Instru-
ments, Inc.) balanced against an atmospheric reference and
calibrated with a mercury manometer. A simultaneous left
ventricular echogram using a 2.25 MHz Irex System II
echo graph and fiberoptic strip chart recorder was obtained.
The frequency response of the pressure recording channel
was flat from 0 to greater than 100 Hz. Proximal coronary
sinus catheterization was performed with a dual thermistor
thermodilution catheter (Wilton-Webster Laboratories) in-
terfaced to a Wheatstone bridge. Thermodilution coronary
sinus blood flow was determined in duplicate using standard
techniques (II) with strict attention paid to placement of
the proximal thermistor within the os of the coronary sinus.
Position was confirmed by both fluoroscopic appearance
throughout the study and hand injections of small amounts
of contrast medium. Aortic and coronary sinus samples for
oxygen saturation (IL Co-oximeter 282) were obtained in
duplicate. In our laboratory, this instrument, routinely pre-
calibrated with human blood, is accurate to within 2%.
Duplicate determinations of oxygen saturation varied by less
than 5%. Inaddition, in seven patients blood oxygen content
was determined directly (Lex-Oj-Con TL) and compared
favorably with the derived oxygen content from determi-
nations of blood oxygen saturation (r = 0.98).
Administration of nitroglycerin or phenylephrine. After
baseline data were recorded, load was altered with sublin-
gual nitroglycerin or intravenous phenylephrine. The desired
end point for administration of both nitroglycerin and phen-
ylephrine was a change in left ventricular systolic pressure
of at least 10 to 20 mm Hg. Care was taken to obtain a
steady state (unchanging left ventricular pressure, heart rate
and coronary blood flow) under the new loading condition.
Repeat left ventricular pressure and coronary blood flow
measurements were taken. Coronary sinus and aortic spec-
imens for oxygen saturation and M-mode echogram were
obtained. Sublingual nitroglycerin was given initially to 14
subjects beginning with 0.4 mg and administration was re-
peated as necessary every 5 minutes until the desired end
point was reached. The mean total nitroglycerin dose was
0.6 ± 0.1 mg. Fifteen patients received intravenous phen-
ylephrine beginning with a 0.1 mg bolus dose that was
repeated at I minute intervals until the desired end point
was achieved. The mean total phenylephrine dose was 0.2
± 0.04 mg. Three patients received both phenylephrine and
nitroglycerin with an intervening repeat control. Patients
received these interventions in alternating sequence in order
to avoid any unintended bias.
Ventriculography and coronary angiography. At the
completion of the study, after return to basal hemodynamic
conditions, diagnostic ventriculography and coronary an-
giography were performed. Informed consent was obtained
from each patient on the day before the study. No untoward
reactions or complications occurred.
Data analysis. Myocardial oxygen consumption (MV02)
was estimated from the product of the thermodilution coro-
nary sinus flow and the aortic-coronary sinus oxygen content
difference. Blood oxygen content was calculated as the product
of the percent blood oxygen saturation and the oxyhemo-
globin binding capacity. Left ventricular ejection fraction
and left ventricular volumes were calculated using the method
of Kennedy et al. (12) from a right anterior oblique ven-
triculogram, after correction for magnification and pin cush-
ion distortion.
In all 32 patients, the simultaneous left ventricular echo-
gram and high fidelity pressure recording (Fig. lA) were
digitized manually on a microcomputer equipped with a high
resolution digitizer (25 iLm) to obtain left ventricular mer-
idional wall stress at 10 ms intervals using the method of
Grossman and coworkers (13) (Fig. IB). Cycles were dig-
itized from the peak of the R wave of the electrocardiogram,
which was considered to represent end-diastole. End-ejec-
tion was defined as the time of cessation of shortening as
assessed from the continuous plot of the left ventricular
internal diameter over time. The shortening load was defined
as the integral of the stress-time curve from the onset of
shortening to the end of shortening (10).
Left ventricular mass was determined from the left ven-
tricular M-mode echogram using a previously validated
method developed in our laboratory (14).
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Table 1. Hem odynamic and Coro nar y Blood Flow Determination s in 32 Pat ient s
Age (yr) Clinical
Case &Sex Diagnosis HR LVI' CBF MVO~ SL LVM EF
I
B 59F Mild MS 8 ~ 110/14 66 8.4 ~ . 3 85 145 0 .5~
P 75 1 ~5 /~0 78 9.9 .I.~O~
~
B 21M Small VSD 60 110/8 In ~u ~ . ~86 161 0.59
I' 60 140/15 .100 .1.1 .0 .1 . 157
.I
B 51F Mild MS 62 110/6 70 9 7 30393 144 0.57
P 60 140/8 85 11.8 4.898
N 63 90/0 60 8.8 ~.659
4
B .13M Mild MS 65 11511 4 115 16.0 2.nO 220 0.65
N 70 105/6 105 15..1 1.526
5
B 51F Atyp CP 70 1.\0/10 180 16.5 .1 .370 1 ~6 0.7.\
N 70 110/6 166 14.9 ~ . ~45
6
B 60F Atyp CP 53 9511 X 78 6.X 1.569 157 0.55
P 45 130/.10 ~05 10.1 3.024
7
B 53M CM 78 I~5112 195 7 . ~ .1 .-16 1 2X I 0.55
P 75 1 70/~O 258 9.5 5.270
8
B 59F MR 102 110/23 ~ 19 ~ 1.5 4.374 303 0.70
P 105 140/28 320 29.8 5.93 1
9
B 43M MR 93 11 5/~ 2 2.18 33.5 4.179 529 0.59
P 100 130/.15 .lIS 41.6 5.185
N 92 110/20 196 25.X 3.65 1
10
B 35M AR 65 130/30 162 ~0 .3 5.lJ43 436 0.66
I' 65 160/45 230 27.4 6.927
II
B 61F MR 60 130118 96 11 .6 ~ .725 160 0.60
P 60 150/30 120 14.8 4.055
12
B 30M VSD 60 120/1 8 105 13.9 ~.464 259 0.64
P 63 140/25 133 16.6 30361
13
B 66M AS 60 220m ~ 12 23.7 3.665 402 0.78
N 63 ~ 10120 180 ~O . I .1 .055
14
B 30F AR 100 130/25 240 30.X 4.:m 247 0.57
N 100 120/20 164 ~~ . I ~ .994
15
B 62M AR 55 150/28 ~6 2 36.3 4.511 390 0.50
N 55 13011 8 ~50 33.3 3.536
16
B 52M AS 92 220/35 m 18.3 4.160 336 0.60
N 92 210/2X 11 0 16.1 3.552
17
B 73M MR 65 125/30 168 ~5 .2 6.350 307 0.74
N 70 110/ 18 120 1 8 . ~ 3.7R7
18
B 67M AS 68 190/25 303 27.9 5.-167 302 0.55
N 71 170/20 ~8 3 25.7 3.866
19
B 4RM MR ri 90110 73 10.6 3.7 17 246 0.36
P 72 110115 86 12.X 5.399
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Table 1. Hemodynamic and Coronary Blood Flow Determinations in 32 Patients (continued)
Age (yr) Clinical
Case &Sex Diagnosis HR LYP CBF MV02 SL LYM EF
20
B 50F CM 69 158/12 240 28.8 7,429 318 0.40
P 66 180/28 281 33.1 9.278
21
B 61M CM 94 180/25 125 19.6 4,469 442 0.30
N 93 160/22 86 13.5 3,807
22
B 53M CM 96 115/35 85 11.8 4,907 443 0.30
P 90 130/50 90 12.3 6,641
23
B 69F HCYD 65 180/18 110 15.5 3,980 243 0.46
P 65 210125 136 19.7 6,420
24
B 55M CM 98 80132 153 20.8 2,643 316 0.25
P 96 92/38 176 25.0 4,144
25
B 63M MR 85 90116 164 21.9 2,695 380 0.45
P 90 100118 188 24.1 3,386
26
B 60M AS 90 155/20 242 27.7 4,795 364 0.42
P 100 170/28 393 36.0 4,946
N 85 150110 200 25.1 3,567
27
B 71M AS 92 160/30 280 38.4 6,390 385 0.30
N 94 154/28 205 27.7 5,021
28
B 69F MR 100 150/20 356 32.5 6,355 281 0.45
N 95 140/16 300 28.5 5,294
29
B 56F HCYD 72 200/28 200 27.2 10,724 156 0.40
N 76 170118 166 20.9 8,700
30
B 64M CM 85 110/30 205 25.2 8,201 461 0.10
N 85 100125 187 22.2 7,013
31
B 48M AS 96 120/30 295 39.8 5.480 554 0.35
N 90 105/20 250 32.5 3,523
32
B 45F HCYD 55 130125 106 12.7 2,180 143 0.68
P 52 160/38 143 18.0 4,354
AR aortic regurgitation; AS = aortic stenosis; Atyp CP = atypical chest pain syndrome; B = baseline; CBF = coronary sinus blood flow
(mllmin); CM = congestive cardiomyopathy; EF = angiographic left ventricular ejection fraction; HCYD = hypertensive cardiovascular disease; HR
= heart rate (beats/min); LYM = left ventricular mass (g); LYP = left ventricular pressure (mm Hg): MR = mitral regurgitation; MS = mitral stenosis;
MV02 = myocardial oxygen consumption (mllmin); N = nitroglycerin; P = phenylephrine; SL = shortening load (X 10' dynes-s/crrr'j: YSD =
ventricular septal defect.
Statistical analysis. Results are expressed as mean ±
standard error of mean, Statistical analysis of results was
performed using a least squares technique for linear regres-
sion, A paired t test comparison was used in the analysis
of changes between control and intervention within the same
patient, and an unpaired t test was used in the comparison
of variables between two patient groups, An analysis of
variance was used in the comparison of variables between
three patient groups, Statistical significance was defined at
a probability (p) value of less than 0.05, Echocardiograph-
ically-derived variables represent the mean of data obtained
from a minimum of 10 cardiac cycles and 2 respiratory
cycles,
Results
Coronary sinus blood flow and MV02• Table I out-
lines the rest and postintervention heart rate, left ventricular
pressure, left ventricular mass, coronary blood flow, MV02
and shortening load for the entire patient group, In normal
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Figure 1. A, Representative simultaneous re-
cordings of M-mode left ventricular echogram
and high fidelity left ventricular pressure in a
patient with severe aortic regurgitation. B, Left
ventricular pressure (P), meridional stress (5),
I A posterior left ventricular wall thickness (T) and
left ventricular internal diameter (0) over a sin-
31'11'1
gle cardiac cycle derived from the data recorded
in panel A. The vertical lines on the stress curve
indicate the onset and end, respectively, of left
S ventricular shortening.
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subjects, coronary blood flow at rest varied from 66 to 180
mllmin (mean 113 ± 14.6) and for the 26 subjects with an
increased mechanical load, coronary flow ranged from 73
to 356 ml/min (mean 190 ± 16.3, p < 0.01). Mean total
MV02 in normal subjects (13.1 ± 1.1) differed significantly
from mean MV02 in patients with heart disease (23.2 ±
1.6 ml/rnin, p < 0.01).
Left ventricular mass and ejection stress. Left ven-
tricular mass ranged from 126 to 220 g (mean 158 ± 13)
in the six normal subjects and 143 to 554 g (mean 330 ±
22, p < 0.001) in the patients with heart disease. The mean
shortening load was 2,620 ± 285 x 101 dyness/crrr' in
the normal subjects and 4,789 ± 380 x 101 dynes-s/crrr'
(range 2,180 to 10,724, P < 0.0 I) in the patients with heart
disease.
Effects of load alteration on ventricular mechanics
and MV02 • Table 2 summarizes the effects of interven-
tions on heart rate, shortening load and MV02 . Nitrogly-
cerin produced significant decreases in shortening load
( - 1,297 ± 152 x 101 dynes' s/crrr' , p < 0.001) and
MV02 (-5.7 ± 0.8 ml/rnin, p < 0.001). In contrast,
phenylephrine produced significant increases in shortening
load (+ 1,412 ± 137 x 101 dyness/crrr', p < 0.001) and
MV02 (+5.5 ± 0.7 ml/rnin, p < 0.001). No significant
change in heart rate with either intervention was noted.
Changes in MV02 correlated closely with changes in coro-
nary blood flow (r = 0.98, P < 0.01).
Influence of left ventricular mass on MV02• For the
group as a whole, rest MV02 correlated weakly ~ith left
ventricular mass (r = 0.57, P< 0.01). However, MV021l00
g was inversely related to left ventricular mass (r = - 0.37,
p < 0.01). In addition, for the patients receiving phenyl-
ephrine, the increase in MV02 was also inversely related
to left ventricular mass (r = -OAI, P < 0.01; Fig. 2).
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Table 2. Effects of Load Alteration on Myocardial Oxygen Consumption, Heart Rate and Shortening Load
Phenylephrine (n = 18)
Nitroglycerin (n = 17)
A Mve2 (ml/min)
+ 5.5 ± 0.7 (p < 0.001)
-5.7 ± 0.8 (p < 0.001)
A HR
-0.3 ± 1.1 (NS)
+0.5 ± 0.9 (NS)
ASL (X la' dynes-s-crrr')
+ 1412 ± 137 (p < 0.001)
-1297 ± 152 (p < 0.001)
A HR = mean change in heart rate; AMVO~ = mean change in myocardial oxygen consumption; ASL = mean change in shortening load: NS =
not significant: p = probability.
Influence of left ventricular function on the relation
between mechanics and MV02• We examined the changes
in coronary flow, MV02 and shortening load after load
alteration in two clinically differentiated groups of patients:
those with no prior history of heart failure (Group I) and
those with a recent history of congestive heart failure (Group
2). The mean angiographic ejection fraction was signifi-
cantly greater in Group I (0.62 ± 0,05) than in Group 2
(0.38 ± 0.04, P < 0.001). In Group I patients receiving
phenylephrine (n = 10), coronary flow and MV02 increased
by40± 1.6and32.1 ± 1.4%, respectively, while in Group
2 patients receiving phenylephrine (n = 8), they increased
by only 20.1 ± l.l and 16.8 ± 0.08%, respectively (p <
0.01). However, shortening load change (IlSL) in Group I
( + 44.1 ± 2.1 %) was not significantly different from that
in Group 2 (+47.5 ± 2.2%). When the change in MV02
was related to the change in shortening load, there were
significant group differences (Fig. 3, Table 3), In subjects
receiving phenylephrine, the mean %IlMV02/% IlSL ratio
was 0.79 ± 0.09 in Group I and 0.35 ± 0.06 in Group 2
(p < 0.005). There was no significant difference in mean
left ventricular mass between Group I and Group 2 (263
vs. 306 g, respectively). Thus, MV02 and coronary blood
75
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W 45
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flow increased less rapidly with increases in shortening load
in patients with clinically decompensated left ventricular
hypertrophy.
For patients receiving nitroglycerin, coronary flow and
MV02 decreased by 14.0 ± 1.5 and 14.4 ± 1.4%, re-
spectively, in Group I compared with 19.0 ± 1.3 and 20.6
± 1.5%, respectively, in Group 2. Additionally, mean %
Il MV02/% IlSL was 0.54 ± 0.09 in Group I versus 1.10
± O. 17 in Group 2 (p < 0.0 I). Mean left ventricular mass
was not significantly different in Groups I and 2 (275 versus
377 g). Thus, MV02 appears to decrease substantially more,
for a given decrease in mechanical load, in the hypertrophied
and mechanically decompensated left ventricle.
Influence of left ventricular function on myocardial
oxygen extraction. Myocardial oxygen extraction also dif-
fered between groups. Among patients receiving phenyl-
ephrine (Table 4), Group 2 patients exhibited lower mean
coronary sinus oxygen saturation and higher mean fractional
oxygen extraction both before and after phenylephrine. There
was no significant change in arteriovenous oxygen differ-
ence, coronary sinus oxygen saturation or fractional ex-
traction of oxygen after phenylephrine for either group,
There was a tendency toward an increased arteriovenous
Figure 2. The increment in myocardial oxygen
consumption (MVOJ in 18 patients receiving
phenylephrine infusion was inversely related to
left ventricular mass (LYM),
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+100
SL = shortening load; other abbreviations as before.
The results of this study indicate a critical role for the
combination of left ventricular dysfunction and left ven-
tricular hypertrophy in modulating the relation between left
ventricular oxygen consumption and alterations in ventric-
ular mechanics, During load augmentation with phenyl-
ephrine, patients with left ventricular hypertrophy and clin-
ical heart failure had smaller increases in myocardialoxygen
consumption (MVOz) in relation to the increase in me-
chanical load than did normal subjects and those with com-
pensated left ventricular hypertrophy. However, these pa-
tients with left ventricular hypertrophy and clinical heart
failure appeared to derive more benefit from load reduction
by exhibiting a larger decrease in MV0 2 in relation to the
decrease in mechanical load than normal subjects. The ob-
served changes in MV0 2 during these physiologic load al-
terations were significantly related to changes in coronary
blood flow, In addition, fractional myocardial oxygen ex-
traction at rest was higher in patients with clinical left ven-
tricular failure and decreased to comparably normal levels
after nitroglycerin load reduction, Myocardial oxygen ex-
tory of heart failure) and Group 2 (clinical heart failure),
we sought to analyze the contribution of left ventricular
hypertrophy alone, to these described differences in the
ratio of change in myocardial oxygen consumption/change
in shortening load (%.:iMV02/ %.:iSL).
For the patients given phenylephrine(Fig. 4A) there was
no significant difference in this index between normal sub-
jects without left ventricular hypertrophy (Group A, mean
index = 0,80, mean left ventricular mass = 166 g) and
subjects with clinically compensated left ventricular hyper-
trophy (Group B, mean index = 0.79, mean left ventricular
mass = 328 g), However, there was a significantdifference
in index between Group A and Group B and subjects with
clinically decompensated left ventricular function and left
ventricular hypertrophy (Group C, mean index = 0.35,
mean left ventricular mass = 298 g). Because left ventric-
ular mass was similar in Groups Band C, left ventricular
pump dysfunction, not hypertrophy per se, is associated with
the abnormal response to load increases.
For the patients given nitroglycerin (Fig, 48), although
there was no statistical difference in index between Group
A (mean index = 0.27) and Group B (mean index = 0.65),
there was a striking difference between Group A and Group
C (mean index = 1,10; P < 0.05), There was a general
tendency toward increasing index values with increasing
degrees of left ventricular dysfunction, but a comparison
between Groups Band C did not show a statistically sig-
nificant difference, There was no difference in left ventric-
ular mass between Group B (mean left ventricular mass =
323 g) and Group C (mean left ventricular mass = 345 g).
Discussion
I 35.5 t 6,1
+100
-100
Phenylephrine
(%AMVOzl%ASL) x 10 2 LYM
Group I 79,6 ± 9.6 263 ± 41
Group 2 35,5 ± 6.1 306 ± 33
p (I vs. 2) < 0.005 NS
Nitroglycerin
Group I 54.0 ± 9.4 275 ± 29
Group 2 110,5 ± 17,8 377 ± 49
p (I vs. 2) < 0,01 NS
T1 79.6 t 9.6
Table 3. Dependence of %.lMVOz/%.lSL With Load Change
on Left Ventricular Pump Function
oxygen difference in Group 2 although this difference did
not reach statistical significance. In contrast, among patients
receiving nitroglycerin (Table 5), fractional oxygen extrac-
tion, significantly higher in Group 2 for the control period,
decreased with nitroglycerin and was not significantly dif-
ferent from the value in Group I after nitroglycerin, Frac-
tional oxygen extraction did not change with nitroglycerin
in Group 1. Thus, myocardial oxygen extraction in patients
with clinical left ventricular failure is higher at rest than in
patients with compensated left ventricular function, This
increased extraction persists with mild load augmentation.
However, with load reduction, the significantly increased
basal oxygen extraction decreases to comparably normal
levels. There was no difference in hemoglobinconcentration
between patient groups,
Role ofleft ventricular hypertrophy. Because left ven-
tricular hypertrophy was common to both Group I (no his-
1I0.5! 17.8I
Figure 3. The mean ratio of the change in myocardial oxygen
consumption (% .l MV02) to the change in shortening load (% .l
SL) with load alteration induced by phenylephrine (upper right)
or nitroglycerin (lower left) is significantly different between pa-
tient groups, Group 2 patients exhibit a blunted response with an
increase in mechanical load but an enhanced response with load
decreases,
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Table 4. Left Ventricular Oxygen Extraction in Patients Receiving Phenylephrine
a-v02 CS", O2 Ex
Pre Post Pre Post Pre Post
Group I II.9±0.5 12.8 ± 0.9 31.8 ± 1.7 30.9 ± 2.2 0.66 ± 0.01 0.67 ± 0.02
•
(n = 10)
Group 2 13.1 ± 0.4 13.1 ± 0.5 24.0 ± 1.0 23.7 ± 1.3 0.75 ± 0.01 0.75 ± 0.01
(n = 8)
P (I vs. 2) NS NS <0.005 <0.025 <0.005 <0.05
a-v02 = arterial-coronary sinus oxygen content difference (mIJIOO ml); CS", = coronary sinus blood oxygen saturation (%); NS = not significant;
O2 Ex = fractional extraction of oxygen; p = probability.
traction did not increase with phenylephrine load augmen-
tation beyond extant high basal levels in either patient group.
Energetic-mechanical relations in left ventricular hy-
pertrophy. To date, little information has been available
on the relation of changes in MVOz to alterations in ven-
tricular mechanics in the setting of left ventricular hyper-
trophy in human beings. Several studies (5,15) have ex-
amined the relation between increasing heart rate with exercise,
atrial pacing or isoproterenol infusion and coronary blood
flow but data on the alterations in ventricular mechanics are
lacking. More recently, several studies have demonstrated
correlations between peak left ventricular circumferential
wall stress at rest and coronary blood flow (2,4) or MVOz
(1) in patients with left ventricular hypertrophy. Unfortu-
nately, similar data obtained from physiologic alterations in
load are not avallable. In this report, we analyzed the re-
lation of the change in MVO z to the change in mechanical
load during pharmacologic load alteration. Each patient served
as his own control thus providing an opportunity to study
both mechanics and energetics under differing loading con-
ditions, but similar heart rates and contractile state (10).
Importance of systolic wall force. The analysis of
changes in MVO z during load alteration must include in-
formation on the mechanical determinants of MVOz. Under
conditions of unchanging heart rate and contractility, MVOz
becomes highly dependent on wall force. It has been shown,
both in the isolated canine heart (16) and in human beings
(10), that changes in the time integral of ejection stress, or
shortening load, correlate closely with changes in MV02.
Shortening load, in fact, by representing the pattern of de-
velopment and maintenance of systolic wall stress, bears a
stronger relation to MVOz than peak stress, mean stress,
tension-time index or left ventricular stroke Work in patients
with left ventricular hypertrophy (10).
Recently, Suga and coworkers (17-19) proposed an ad-
ditional component to the determinants of MV'Oz. Exam-
ining both the pressure-volume loop and potential energy
at end-systole, they found, in an isolated heart preparation,
high correlations between MVOz and the summation of these
two energies. Thus, while it is clear that external mechanical
work, alone, is a poor predictor of MVOz (18), the area of
the developed pressure-volume loop and the area of the end-
systolic potential energy triangle contribute significantly to
MVOz under the conditions of their study. The relevance
of these important findings to our patients with various de-
grees of left ventricular hypertrophy and left ventricular
dysfunction is unclear. The administration of pheny lephrine
contributes to a substantial increase in pressure work, al-
though ventricular size does increase, while nitroglycerin
contributes to decreases in both pressure- and volume-type
work. Therefore, from the standpoint of external ventricular
work, the interventions used in the present study, albeit
physiologic, may cause the true impact of changing loading
conditions on MVOz to be underestimated. Thus, by fol-
lowing changes in left ventricular pressure, the contribution
of external work to MVOz may be overestimated. However,
wall stress-and, in particular, shortening load-takes into
account not only pressure but dimension and thus allows
for Changing pressure and dimension in an analysis of the
variation in MVOz with load changes. Thus, phenylephrine
Table 5. Left Ventricular Oxygen Extraction in Patients Receiving Nitroglycerin
a-v02 CS,", O2 Ex
Pre Post Pre Post Pre Post
Group I 12.5 ± 0.8 12.6 ± 0.9 28.3 ± 2.5 27.5 ± 2.6 0.70 ± 0.02 0.71 ± 0.02t
(n = 10)
Group 2 12.9 ± 0.9 12.7 ± 0.8 22.2 ± 1.2 24.1 ± 1.1 0.76 ± 0.01 0.73 ± 0.01*
(n = 7)
P (I vs. 2) NS NS NS NS 0.05 NS
*p < 0.05 (paired t test, pre vs. post, Group 2); tp = NS (paired t test, pre vs. post, Group I). Abbreviations as in Table 4.
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Figure 4. A, Differences in the ratio of changes in MV02 and
shortening load are noted between subgroups of patients with left
ventricular hypertrophy . Only patients with left ventricular hy-
pertrophy and left ventricular dysfunction (C) exhibit a blunted
response with phenylephrine load increases. D, Patients with left
ventricular hypertrophy anddysfunction (C) exhibit a significantly
enhanced response to nitroglycerin load reduction.
administration resulted in increases in MY02 and shortening
load and nitroglycerin resulted in decreases in MY02 and
shortening load.
Matching of MV02 to mechanical load in clinical left
ventricular failure. The ratio, change in myocardial ox-
ygen consumption/change in shortening load (% Li MY02/%
LiSL), is not fixed. In subjects with clinical left ventricular
dysfunction receiving phenylephrine this ratio was reduced.
There were similar increases in coronary flow and MY02
in normal subjects and in subjects with clinically compen-
sated left ventricular hypertrophy, suggesting that left ven-
tricular dysfunction is the substrate for the altered coronary
flow response. The changes observed with nitroglycerin-
induced load reduction were of great interest. Patients with
left ventricular dysfunction and hypertrophy benefited sig-
nificantly, from an energetics standpoint, from load reduc-
tion. The %LiMY0 2/% Li SL ratio, now reflecting the de-
crease in oxygen consumption in relation to load, was
significantly and dramatically higher in this group than in
normal subjects, while patients with clinically compensated
left ventricular hypertrophy demonstrated an intermediate
response. Thus, in the group with an impaired increase in
coronary flowand MY02 with load increases, load reduction
markedly diminished MY02 , more so than in normal sub-
jects. In addition, the higher fractional oxygen extraction
in patients with clinical heart failure decreased to compar-
ably normal levels after the administration of nitroglycerin.
The implications of these data for the energetics of the
failing ventricle support the theoretic beneficial effect of
load reduction on energy supply-demand relations (22).
Methodologic considerations. Several methodologic
issues must be considered in evaluating these data. The
thermodilution technique for estimation of coronary blood
flow has been utilized extensively in the past several years
(11 ). However, in the absence of an accepted reference
standard for the quantitation of coronary blood flow in hu-
man beings, it is difficult to be certain of the accuracy of
this particular method. Thus, data on the estimation of total
left ventricular coronary blood flow must be viewed with
caution in light of the great dependency of these data on
catheter position within the coronary sinus. Although we
paid meticulous attention throughout these studies to prox-
imal positioning and sampling, it is still not absolutely cer-
tain that the measurement obtained represents total left ven-
tricular coronary flow. However, in the absence of coronary
disease, with each patient serving as his own control, and
with little change in heart rate, data thus collected should
be a reliable index of changes in flow.
Second, we relied on meridional stress rather than cir-
cumferential stress because the M-modeechogramexamines
only the left ventricular short-axis diameter. Circumferential
stress data would have been useful but require measurement
of the ventricular long axis and radii of curvature in both
planes. This would have necessitated either a second ven-
triculogram (often with some risk) or simultaneous use of
two-dimensional echocardiography to determine left ven-
tricular length (the latter lacks sufficientrepetition frequency
for the digitization of dimensional data). In this study. sig-
nificant alterations in meridional stress were achieved with
small, physiologic changes in ventricular size and pressure.
We previously showed (21) that similar load changes do not
change the ratio of the major to the minor axes of the left
ventricle and that stress reductions are comparable in both
planes. Further, the ability to use each patient as his own
control facilitates analysis of directional changes in stress
and makes absolute values of secondary importance in this
study.
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Implications. This analysis relating myocardial oxygen
consumption to an index of mechanical demand, the short-
ening load, has demonstrated an abnormality in the coupling
of oxygen consumption to mechanics in left ventricular hy-
pertrophy. We used the index change in myocardial oxygen
consumption/change in shortening load (%aMVO:J%a SL),
to describe a state of diminished capability to increase coro-
nary flow in patients left ventricular hypertrophy andclinical
left ventriculardysfunction. In addition , this index appeared
useful in demonstrating that nitrate administration in left
ventricularhypertrophy with left ventricular dysfunction ap-
pears to confer a decided benefit from an energetics stand-
point. By relatingchangesin oxygenconsumption to a phys-
iologic variable suchas the shortening load, a more meaningful
insight into the pathophysiology of altered coronary flow
responses in left ventricular hypertrophy is possible.
We gratefully acknowledge the expert technical assistanceof Ted Plappert
and Ali Muhammad and the secretarial assistance of Geri McCausland.
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